Dynamic Measures of Neurochemistry in Mood Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Depression
Interventions
DRUG

sertraline

Patients will be assigned by random selection to sertraline (50mg daily for one week, then 100mg daily) or bupropion (SR formulation, 150 mg daily for 1 week, then 150 mg BID). A second CSF collection will be completed after 4 weeks of the sertraline treatment (during week 5).

DRUG

bupropion

Patients will be assigned by random selection to sertraline (50mg daily for one week, then 100mg daily) or bupropion (SR formulation, 150 mg daily for 1 week, then 150 mg BID). A second CSF collection will be completed after 4 weeks of the sertraline treatment (during week 5).

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT00178828 - Dynamic Measures of Neurochemistry in Mood Disorders | Biotech Hunter | Biotech Hunter